Silencing of SRRM4 suppresses microexon inclusion and promotes tumor growth across cancers.

Consistent with the down-regulated expression, we found an increase in SRRM4 promoter methylation that was highly significant in tumors from all tissues, even in liver ( p < 0.001; Wilcoxon–Mann–Whitney test; Fig 2B , S2 Data ).

also in 132,142 other papers